{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:39:52Z","timestamp":1694630392846},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s11934-005-0032-3","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T18:53:34Z","timestamp":1181069614000},"page":"403-404","source":"Crossref","is-referenced-by-count":2,"title":["Solifenacin versus tolterodine\u2014 A head-to-head study: Finally! but not final?"],"prefix":"10.1007","volume":"6","author":[{"given":"David R.","family":"Staskin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger R.","family":"Dmochowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Wein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"32_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4065\/76.4.358","volume":"76","author":"RA Appell","year":"2001","unstructured":"Appell RA, Sand P, Dmochowski R, et al.: Prospective, randomized, controlled trial of extended-release oxybutynin, chloride, and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. Mayo Clin Proc 2001, 76:358\u2013363.","journal-title":"Mayo Clin Proc"},{"key":"32_CR2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4065\/78.6.687","volume":"78","author":"AC Diokno","year":"2003","unstructured":"Diokno AC, Appell RA, Sand PK, et al.: Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA Trial. Mayo Clin Proc 2003, 78:687\u2013695.","journal-title":"Mayo Clin Proc"},{"key":"32_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s11934-003-0025-z","volume":"4","author":"SA MacDiarmid","year":"2003","unstructured":"MacDiarmid SA: Overactive bladder: improving the efficacy of anticholinergics by dose escalation. Curr Urol Rep 2003, 4:446\u2013451.","journal-title":"Curr Urol Rep"},{"key":"32_CR4","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0022-5347(05)68810-6","volume":"161","author":"RU Anderson","year":"1999","unstructured":"Anderson RU, Mobley D, Blank B, et al.: Once-daily controlled versus immediate-release oxybutynin chloride for urge urinary incontinence. J Urol 1999, 161:1809\u20131812.","journal-title":"J Urol"},{"key":"32_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0090-4295(99)00259-9","volume":"54","author":"DM Gleason","year":"1999","unstructured":"Gleason DM, Susset J, White C, et al.: Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinence. Urology 1999, 54:420\u2013423.","journal-title":"Urology"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-005-0032-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-005-0032-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-005-0032-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-005-0032-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T11:55:16Z","timestamp":1652615716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-005-0032-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1007\/s11934-005-0032-3","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}